G. ÖZBEY Et Al. , "Evaluation of the Relationships Between ABCB1 C3435T and G2677T/A Polymorphisms and Clinical Response to Venlafaxine in Patients with Major Depressive Disorder," 11th Congress of the European Association for Clinical Pharmacology and Therapeutics , vol.35, Cenevre, Switzerland, pp.66, 2013
ÖZBEY, G. Et Al. 2013. Evaluation of the Relationships Between ABCB1 C3435T and G2677T/A Polymorphisms and Clinical Response to Venlafaxine in Patients with Major Depressive Disorder. 11th Congress of the European Association for Clinical Pharmacology and Therapeutics , (Cenevre, Switzerland), 66.
ÖZBEY, G., Çam Çelikel, F., Elbozan Cumurcu, B., Kan, D., Yücel, B., Hasbek, E., ... Perçin, F.(2013). Evaluation of the Relationships Between ABCB1 C3435T and G2677T/A Polymorphisms and Clinical Response to Venlafaxine in Patients with Major Depressive Disorder . 11th Congress of the European Association for Clinical Pharmacology and Therapeutics (pp.66). Cenevre, Switzerland
ÖZBEY, GÜL Et Al. "Evaluation of the Relationships Between ABCB1 C3435T and G2677T/A Polymorphisms and Clinical Response to Venlafaxine in Patients with Major Depressive Disorder," 11th Congress of the European Association for Clinical Pharmacology and Therapeutics, Cenevre, Switzerland, 2013
ÖZBEY, GÜL Et Al. "Evaluation of the Relationships Between ABCB1 C3435T and G2677T/A Polymorphisms and Clinical Response to Venlafaxine in Patients with Major Depressive Disorder." 11th Congress of the European Association for Clinical Pharmacology and Therapeutics , Cenevre, Switzerland, pp.66, 2013
ÖZBEY, G. Et Al. (2013) . "Evaluation of the Relationships Between ABCB1 C3435T and G2677T/A Polymorphisms and Clinical Response to Venlafaxine in Patients with Major Depressive Disorder." 11th Congress of the European Association for Clinical Pharmacology and Therapeutics , Cenevre, Switzerland, p.66.
@conferencepaper{conferencepaper, author={GÜL ÖZBEY Et Al. }, title={Evaluation of the Relationships Between ABCB1 C3435T and G2677T/A Polymorphisms and Clinical Response to Venlafaxine in Patients with Major Depressive Disorder}, congress name={11th Congress of the European Association for Clinical Pharmacology and Therapeutics}, city={Cenevre}, country={Switzerland}, year={2013}, pages={66} }